Bilateral Radiation Optic Neuropathy Following Concurrent Chemotherapy and Radiation in Glioblastoma.
Autorzy:
Thakkar JP; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA. Slevin JT; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.; Neurology Service, Veterans Affairs Medical Center, Lexington, Kentucky, USA. Smith CD; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA. Sudhakar P; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA. St Clair W; Department of Radiation Oncology, University of Kentucky, Lexington, Kentucky, USA. Villano JL; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.; Department of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Pokaż więcej
Źródło:
Neuro-ophthalmology (Aeolus Press) [Neuroophthalmology] 2017 May 30; Vol. 41 (5), pp. 287-290. Date of Electronic Publication: 2017 May 30 (Print Publication: 2017).
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.
Autorzy:
Hilal T; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA. Nakazawa M; University of Kentucky College of Medicine, Lexington, KY, USA. Hodskins J; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. Villano JL; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. Mathew A; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. Goel G; Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. Wagner L; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. Arnold SM; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. DeSimone P; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. Anthony LB; Division of Medical Oncology, University of Kentucky, Markey Cancer Center, Lexington, KY, USA. Hosein PJ; Hematology/Oncology, University of Miami School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Aug 30; Vol. 17 (1), pp. 602. Date of Electronic Publication: 2017 Aug 30.
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)
National cancer database analysis of outcomes in pediatric glioblastoma.
Autorzy:
Liu M; Division of Cancer Biostatistics, University of Kentucky, Lexington, Kentucky.; Markey Cancer Center, University of Kentucky, Lexington, Kentucky. Thakkar JP; Department of Neurology, University of Kentucky, Lexington, Kentucky. Garcia CR; Markey Cancer Center, University of Kentucky, Lexington, Kentucky. Dolecek TA; Division of Epidemiology and Biostatistics and Institute for Health Research and Policy, School of Public Health, University of Illinois at Chicago, Chicago, Illinois. Wagner LM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Department of Pediatric Hematology and Oncology, University of Kentucky, Lexington, Kentucky.; Department of Medicine, University of Kentucky, Lexington, Kentucky. Dressler EVM; Department of Biostatistical Sciences, School of Medicine, Wake Forest Baptist Health, Winston Salem, North Carolina. Villano JL; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Department of Neurology, University of Kentucky, Lexington, Kentucky.; Department of Medicine, University of Kentucky, Lexington, Kentucky.; Department of Neurosurgery, University of Kentucky, Lexington, Kentucky.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2018 Apr; Vol. 7 (4), pp. 1151-1159. Date of Electronic Publication: 2018 Mar 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Autorzy:
Liau LM; University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. . Ashkan K; King's College London School of Medical Education, London, UK. Tran DD; University of Florida, Gainesville, FL, USA. Campian JL; Washington University, St. Louis, MO, USA. Trusheim JE; Abbott Northwestern Hospital, Minneapolis, MN, USA. Cobbs CS; Swedish Medical Center, Swedish Neuroscience Institute, Seattle, WA, USA. Heth JA; University of Michigan Medical School, Ann Arbor, MI, USA. Salacz M; University of Kansas Cancer Center, Kansas City, KS, USA. Taylor S; University of Kansas Cancer Center, Kansas City, KS, USA. D'Andre SD; Sutter Institute for Medical Research, Sacramento, CA, USA. Iwamoto FM; Columbia University Medical Center, New York, NY, USA. Dropcho EJ; Indiana University Simon Cancer Center, Indianapolis, IN, USA. Moshel YA; Overlook Medical Center, Summit, NJ, USA. Walter KA; University of Rochester Medical Center, Rochester, NY, USA. Pillainayagam CP; Rush University Medical Center, Rochester, USA. Aiken R; Rutgers Cancer Institute, New Brunswick, NJ, USA. Chaudhary R; University of Cincinnati Medical Center, Cincinnati, OH, USA. Goldlust SA; Hackensack University Medical Center, Hackensack, NJ, USA. Bota DA; UC Irvine Medical Center, Irvine, CA, USA. Duic P; Winthrop-University Hospital, Mineola, NY, USA. Grewal J; NYU Winthrop Hospital, Mineola, NY, USA. Elinzano H; Rhode Island Hospital, Providence, RI, USA. Toms SA; Rhode Island Hospital, Providence, RI, USA. Lillehei KO; University of Colorado Hospital, Aurora, CO, USA. Mikkelsen T; Henry Ford Health System, Detroit, MI, USA. Walbert T; Henry Ford Health System, Detroit, MI, USA. Abram SR; St. Thomas Research Institute, Nashville, TN, USA. Brenner AJ; University of Texas Health Science Center, San Antonio, TX, USA. Brem S; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Ewend MG; University of North Carolina, Chapel Hill, NC, USA. Khagi S; University of North Carolina, Chapel Hill, NC, USA. Portnow J; City of Hope National Medical Center, Duarte, CA, USA. Kim LJ; Thomas Jefferson University, Philadelphia, PA, USA. Loudon WG; St. Joseph Hospital, Newport Beach, CA, USA. Thompson RC; Vanderbilt University, Nashville, TN, USA. Avigan DE; Beth Israel Deaconess Medical Center, Boston, MA, USA. Fink KL; Baylor University Medical Center, Dallas, TX, USA. Geoffroy FJ; Illinois CancerCare, Peoria, IL, USA. Lindhorst S; Medical University of South Carolina, Charleston, SC, USA. Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami, FL, USA. Sloan AE; University Hospitals Case Medical Center, Cleveland, OH, USA. Schackert G; University Hospital Carl-Gustav-Carus of Technical University, Dresden, Germany. Krex D; University Hospital Carl-Gustav-Carus of Technical University, Dresden, Germany. Meisel HJ; BG-Klinikum Bergmannstrost, Halle, Germany. Wu J; Tufts University School of Medicine, Boston, MA, USA. Davis RP; Stony Brook University, Stony Brook, NY, USA. Duma C; Hoag Cancer Center, Newport Beach, CA, USA. Etame AB; H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA. Mathieu D; CHUS-Hopital Fleurimont, Sherbrooke University, Sherbrooke, QC, Canada. Kesari S; UCSD Health System, UC San Diego, San Diego, CA, USA. Piccioni D; UCSD Health System, UC San Diego, San Diego, CA, USA. Westphal M; Neurochirurgische Klinik University Clinic Hamburg-Eppendorf, Hamburg, Germany. Baskin DS; Houston Methodist, Houston, TX, USA. New PZ; Houston Methodist, Houston, TX, USA. Lacroix M; Geisinger Health System, Danville, PA, USA. May SA; Klinikum Chemnitz GGMBH, Chemnitz, Germany. Pluard TJ; Saint Luke's Cancer Institute, Kansas City, MO, USA. Tse V; Kaiser Permanente Northern California, Redwood City, CA, USA. Green RM; Kaiser Permanente Southern California, Los Angeles, CA, USA. Villano JL; University of Kentucky College of Medicine, Lexington, KY, USA. Pearlman M; Colorado Neurological Institute, Englewood, CO, USA. Petrecca K; Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada. Schulder M; Northwell Hofstra School of Medicine, Lake Success, NY, USA. Taylor LP; Department of Neurology, Alvord Brain Tumor Center, University of Washington, Seattle, WA, USA. Maida AE; Northwest Biotherapeutics Inc., Bethesda, MD, USA. Prins RM; University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Cloughesy TF; University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Mulholland P; University College Hospitals, London, UK. Bosch ML; Northwest Biotherapeutics Inc., Bethesda, MD, USA. .
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
